Analysis

PremiumFeatures

OCT China 2026: China becoming ‘centre of gravity’ in global clinical trial sector

China’s rapid growth in recent years has sent ripples across the pharmaceutical sector. The country has experienced significant growth over…

Projects

Apretude (cabotegravir) for the Treatment of HIV-1 Pre-Exposure Prevention (PrEP), US

PremiumFeatures

CTS China 2026: Building resilience for Chinese biotechs to go global

Features

Podcast: Beyond AI: Why patient-centric clinical trials matter now

PremiumFeatures

Osaka has the science. Now it needs the business

Comment

A practical framework for choosing e-signatures in global trials

Projects

ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of HER2-positive advanced gastric cancer

Projects

ZENBEXUS (iberdomide) for the Treatment of Multiple Myeloma, US

Analysis

How real-world evidence can directly support innovation

Analysis

PPD affects races similarly, inequities lie in mental healthcare

GlobalData Healthcare

Analysis

Psychedelic treatments for mental health: Is there substance behind the hype?

News

Can Elon Musk’s Neuralink be trusted to put chips in your brain?

News

IRA lawsuits will be vital test of US’ ability to regulate pharma market

Analysis

How sovereign wealth funds are affecting industries and macroeconomics

Analysis

How sovereign wealth funds are affecting industries and macroeconomics

Analysis

Why does Kuwait struggle to attract FDI?

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close